Finance

Lists
ZBH:NYSE
Zimmer Biomet Holdings, Inc
$ 91.34
-0.31%
(-0.28) 1D
$ 91.34
0.00% (0.00)
After hours
Closed: 9-р сарын 29, 16:00:07 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBH...
Open
$ 90.96
High
$ 91.59
Low
$ 90.60
Mkt. cap
17.42 тэрбум
Avg. vol.
1.83 сая
Volume
1.46 сая
Dividend
1.05%
Quarterly dividend
$ 0.24
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
22.23
52-wk high
$ 106.88
52-wk low
$ 79.12
EPS
$ 4.11
Beta
0.47
Shares outstanding
190.74 сая
No. of employees
17 мян
Open
$ 90.96
High
$ 91.59
Low
$ 90.60
Mkt. cap
17.42 тэрбум
Avg. vol.
1.83 сая
Volume
1.46 сая
Dividend
1.05%
Quarterly dividend
$ 0.24
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
22.23
52-wk high
$ 106.88
52-wk low
$ 79.12
EPS
$ 4.11
Beta
0.47
Shares outstanding
190.74 сая
No. of employees
17 мян
News stories
From web sources and news partners
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17 мян
Founded1927
HeadquartersWarsaw, Индиана, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 18 analysts giving stock ratings to ZBH in the past 3 months
Buy
Buy
6
Hold
12
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for ZBH in the last 3 months.
Highest
Current $ 91.34
$ 120.00 (+31.38%)
Average
$ 106.07 (+16.13%)
Lowest
$ 93.00 (+1.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Hold
Maintained
$ 110.00
+20.4%
09/25/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$ 106.00
+16%
09/16/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$ 117.00
+28.1%
08/17/2026
Joanne Wuensch
Citi
Hold
Maintained
$ 99.00
+8.4%
08/13/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$ 100.00
+9.5%
08/10/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
$ 104.00
+13.9%
08/06/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
$ 98.00
+7.3%
08/06/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
08/06/2026
Patrick Wood
UBS
Buy
Maintained
$ 120.00
+31.4%
08/06/2026
Lee Hambright
Bernstein
Hold
Maintained
$ 93.00
+1.8%
08/06/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$ 110.00
+20.4%
08/06/2026
Vik Chopra
BMO Capital
Hold
Maintained
$ 96.00
+5.1%
08/06/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
$ 103.00
+12.8%
08/06/2026
Kendall Au
RBC Capital
Buy
Reiterated
$ 110.00
+20.4%
08/05/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/05/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$ 115.00
+25.9%
08/05/2026
Danielle Antalffy
UBS
Buy
Upgraded
$ 115.00
+25.9%
07/28/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/23/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
$ 101.00
+10.6%
07/13/2026
Unknown Analyst
BMO Capital
Hold
Initiated
$ 95.00
+4%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$ 110.00
+20.4%
07/06/2026
Caitlin Cronin
Canaccord Genuity
Hold
Reiterated
$ 83.00
-9.1%
04/29/2026
David Turkaly
Citizens JMP
Buy
Maintained
$ 105.00
+15%
04/29/2026
Matt Miksic
Barclays
Sell
Maintained
$ 94.00
+2.9%
04/29/2026
Mike Kratky
Leerink Partners
Hold
Initiated
$ 101.00
+10.6%
04/13/2026
David Roman
Goldman Sachs
Sell
Maintained
$ 88.00
-3.7%
02/10/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 2.07 / $ 2.01
+2.99%beat
Revenue / Est. (USD)
2.18 тэрбум / 2.14 тэрбум
+1.95%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.00 тэрбум
2.24 тэрбум
2.09 тэрбум
2.18 тэрбум
Cost of goods sold
559.30 сая
795.50 сая
564.20 сая
635.50 сая
Cost of revenue
559.30 сая
795.50 сая
564.20 сая
635.50 сая
Research and development expenses
115.90 сая
118.70 сая
103.40 сая
104.80 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
809.40 сая
838.50 сая
846.20 сая
882.30 сая
Operating expense
1.10 тэрбум
1.13 тэрбум
1.11 тэрбум
1.15 тэрбум
Total operating expenses
1.66 тэрбум
1.93 тэрбум
1.68 тэрбум
1.79 тэрбум
Operating income
340.30 сая
313.40 сая
410.80 сая
391.00 сая
Other non operating income
6.20 сая
15.10 сая
5.50 сая
6.00 сая
EBT including unusual items
279.20 сая
97.90 сая
301.30 сая
255.10 сая
EBT excluding unusual items
269.30 сая
250.00 сая
340.20 сая
320.80 сая
Income tax expense
48.00 сая
-39.90 сая
63.00 сая
55.50 сая
Effective tax rate
17.19%
-40.76%
20.91%
21.76%
Other operating expenses
-
-
-
-
Net income
230.90 сая
139.30 сая
238.10 сая
198.30 сая
Net profit margin
11.54%
6.21%
11.41%
9.11%
Earnings per share
1.90
2.42
2.09
2.07
Interest and investment income
-
-
-
-
Interest expense
-75.40 сая
-71.90 сая
-68.80 сая
-72.90 сая
Net interest expenses
-75.40 сая
-71.90 сая
-68.80 сая
-72.90 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
623.90 сая
597.40 сая
680.80 сая
661.80 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс